EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC 4.0

Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study

Qingyun Cai iD, Ting Xie, Hongjian Gong, Wenjie Zhang, Lixin Guo iD, Qi Pan iD

Diabetes/Metabolism Research and Reviews · 2026-05 · 42 (4)

DOI: 10.1002/dmrr.70173 ↗

At a glance

Kohortenstudie in Diabetes/Metabolism Research and Reviews, published online on 2026-04-28. Written by Qingyun Cai and 5 co-authors. Institution: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Beijing, China. Major MEDLINE topics: C-Peptide, Diabetic Neuropathies, Fasting, Diabetes Mellitus, Type 2. 27 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project of china.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

To determine whether recovery of fasting C‐peptide (ΔFCP) reduces deterioration in sudomotor small‐fibre function, whether a threshold exists, and whether associations are complication‐specific.

Methods

Retrospective real‐world cohort of 288 hospitalised adults with diabetes with repeated fasting C‐peptide and Sudoscan electrochemical skin conductance (ESC). Deterioration in sudomotor small‐fibre function was defined as worsening foot ESC. Large‐fibre neuropathy (LFN) and diabetic kidney disease (DKD) progression were assessed by nerve conduction and kidney outcomes. Cox models, restricted cubic splines, maximally selected rank statistics, and subgroup/landmark/sensitivity analyses were performed.

Results

Over a median 2.2 years, higher ΔFCP was independently associated with lower risk of deterioration in sudomotor small‐fibre function, but not with LFN or DKD progression. Highest versus lowest ΔFCP tertile: adjusted HR 0.31 (95% CI 0.14–0.69; p < 0.001). An optimal ΔFCP cutoff of 126.8 pmol/L was identified; ΔFCP ≥ 126.8 pmol/L was associated with a 66% lower risk of sudomotor deterioration (HR 0.34, 95% CI 0.17–0.69; p < 0.001), remaining robust in landmark and sensitivity analyses. Baseline C‐peptide mediated little of the association.

Conclusions

Endogenous fasting C‐peptide recovery is linked to a clinically meaningful, threshold‐dependent reduction in the progression of sudomotor small‐fibre dysfunction, supporting β ‐cell preservation/recovery as targets in early diabetic neuropathy.

Subjects

MeSH terms (MEDLINE)

C-PeptideDiabetic NeuropathiesFastingDiabetes Mellitus, Type 2BiomarkersHumansFemaleRetrospective StudiesDisease ProgressionMaleMiddle AgedAgedPrognosisFollow-Up StudiesNerve Conduction Studies

Author keywords

C‐peptide recoveryclinical translationdiabetic peripheral neuropathysmall fibre neuropathysudomotor dysfunction

Substances

C-PeptideBiomarkers

Authors and institutions

  • Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Beijing, China.
  • Peking Union Medical College Graduate School, Chinese Academy of Medical Sciences, Beijing, China.

ORCID profiles: Qingyun Cai, Lixin Guo, Qi Pan

Funding

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project of china

Cite

APA

Cai, Q., Xie, T., Gong, H., Zhang, W., Guo, L., & Pan, Q. (2026). Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study. Diabetes/Metabolism Research and Reviews, 42(4). https://doi.org/10.1002/dmrr.70173

Vancouver

Cai Q, Xie T, Gong H, Zhang W, Guo L, Pan Q. Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study. Diabetes/Metabolism Research and Reviews. 2026;42(4). doi:10.1002/dmrr.70173

BibTeX
@article{Cai2026,
  author = {Cai, Qingyun and Xie, Ting and Gong, Hongjian and Zhang, Wenjie and Guo, Lixin and Pan, Qi},
  title = {Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {4},
  doi = {10.1002/dmrr.70173}
}
Start for free →